Loading clinical trials...
Loading clinical trials...
Evaluation of different glycemic variations between the dialysis period and non-dialysis period in two groups: nondiabetic and diabetic patients undergone two different hemodialysis methods. Thirty-six patients, males and females, aged 50-80 years, with end stage renal disease (ESRD) will undergo hemodialysis and continuous glucose monitoring (CGM). The investigators will evaluate also inflammation markers before and after the different hemodialysis methods.
Age
50 - 80 years
Sex
ALL
Healthy Volunteers
No
IRCCS Policlinico San Matteo
Pavia, Italy
Start Date
July 31, 2009
Primary Completion Date
May 19, 2014
Completion Date
December 22, 2014
Last Updated
May 24, 2022
36
ACTUAL participants
Continuous Glucose Monitoring (CGM)
DEVICE
Lead Sponsor
University of Pavia
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07296484